Skip to main content
SpringerLink
Log in

A prolactin-secreting tumor in a patient with Klinefelter’s syndrome: A case report

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We report the case of a patient with Klinefelter’s syndrome who developed a prolactin (PRL)-secreting tumor. The patient developed headaches, visual alterations and also symptoms of hypogonadism despite appropriate testosterone (T) replacement therapy. The diagnosis of hyperprolactinemia was then suspected. The laboratory findings confirmed the hypothesis, showing high levels of serum PRL. The patient was initially treated with oral bromocriptine, and afterwards with the injectable form. There was a marked decrease in PRL levels and in tumor size. Although some neoplasms, like breast carcinoma and germ cell tumors, are known to occur more frequently in patients with Klinefelter’s syndrome, an association with PRL-secreting tumor has not been reported yet. In conclusion, symptoms of hypogonadism in patients with Klinefelter’s syndrome receiving appropriate T replacement therapy can suggest the presence of hyperprolactinemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mukerjee D., Bowen J., Anderson D.E. Simian Papovavirus 40 transformation of cells from cancer patient with XY/XXY mosaic Klinefelter’s syndrome. Cancer Res. 30: 1769, 1970.

    PubMed  CAS  Google Scholar 

  2. Scheike O., Visfeldt J., Petersen B. Male breast cancer. Acta Path. Microbiol. 81: 352, 1973.

    CAS  Google Scholar 

  3. Pascual J., Liano F., Garcia-Villanueva A., Salvador J.L., Herrero J.A., Ortuno J. Isolated primary aldosteronism in patient with adrenal carcinoma and XY/XXY mosaic Klinefelter’s syndrome. J. Urol. 144: 1454, 1990.

    PubMed  CAS  Google Scholar 

  4. Carroll P.R., Morse M.J., Koduro P.P.K., Chaganti R.S.K. Testicular germ cell tumor in patient with Klinefelter’s syndrome. Urology 31: 72, 1988.

    Article  PubMed  CAS  Google Scholar 

  5. Lee M.W., Stephens R.L. Klinefelter’s syndrome and extragonadal germ cell tumors. Cancer 60: 1053, 1987.

    Article  PubMed  CAS  Google Scholar 

  6. Konig R., Schonberger W., Grimm W. Mediastinales terato-carzinom und hypophysenstielgerminom bei einem patienten mit Klinefelter syndrom. Klin. Pediatr. 202: 53, 1990.

    Article  CAS  Google Scholar 

  7. Gohji K., Goto A., Takenaka A., Arakawa S., Matumoto D., Hikosaka K., Kamidomo S. Extragonadal germ cell tumor in the retrovesical region associated with Klinefelter’s syndrome: a case report and review of literature. J. Urol. 141: 133, 1989.

    PubMed  CAS  Google Scholar 

  8. Schwartz D., Root A.W. The Klinefelter syndrome of testicular dysgenesis. Endocrinol. Metab. Clin. North Am. 20: 153, 1991.

    PubMed  CAS  Google Scholar 

  9. Mamunes P., Lapidus P.H., Abbot J.A., Roath S. Acute leukaemia and Klinefelter’s syndrome. Lancet 2: 26, 1961.

    Article  PubMed  CAS  Google Scholar 

  10. Liang R., Woo E., Ho F., Collins R., Choy D., Ma J. Klinefelter’s syndrome and primary central nervous system lymphoma. Med. Pediatr. Oncol. 18: 236, 1990.

    Article  PubMed  CAS  Google Scholar 

  11. Kleczkowska A., Fryns J.P., Van den Berghe H. X-chromosome polysome in male. Hum. Genet. 80: 16, 1988.

    Article  PubMed  CAS  Google Scholar 

  12. Arduino L.J., Glucksman M.A. Interstitial cell tumor of the testis associated with Klinefelter’s syndrome: a case report. J. Urol. 89: 246, 1963.

    PubMed  CAS  Google Scholar 

  13. Fujita K., Fujita H.M. Klinefelter’s syndrome and bladder cancer. J. Urol. 116: 836, 1976.

    PubMed  CAS  Google Scholar 

  14. Beuers U., Richter W.O., Ritter M.M., Wiebecke B., Schwandt P. Klinefelter’s syndrome and liver adenoma. J. Clin. Gastroenterol. 13: 214, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Nakano Y., Sato A., Iwata M., Okano A., Hayakawa H., Chida K., Honda K. A case of Klinefelter’s syndrome associated with lung cancer and RA lung. Nippon Kyobu Shikkan Gakkai Zasshi 29: 495, 1991.

    PubMed  CAS  Google Scholar 

  16. Pienkos E.J., Meisner R.F. Adenocarcinoma of the prostate in a 41-year-old man with XXY karyotype and chronic lymphocytic leukemia: report of a case. J. Urol. 145: 148, 1991.

    PubMed  CAS  Google Scholar 

  17. Grossman A., Besser G.M. Prolactinomas. Br. Med. J. 290: 182, 1985.

    Article  CAS  Google Scholar 

  18. Lengyel A.M.J., Mussio W., Imamura P., Vieira J.G.H., Lancranjan I. Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenoma. Fertil. Steril. 59: 980, 1993.

    PubMed  CAS  Google Scholar 

  19. Moult P.J.A., Rees L.H., Besser G.M. Pulsatile gonadotrophin secretion in hyperprolactinemic amenorrhoea and the response to bromocriptine therapy. Clin. Endocrinol. (Oxf) 16: 153, 1982.

    Article  CAS  Google Scholar 

  20. Carter J.N., Tyson M.D., Tolis G., Vliet V.S., Faiman C., Friesen H.G. Prolactin-secreting tumors and hypogonadism in 22 men. N. Engl. J. Med. 299: 847, 1978.

    Article  PubMed  CAS  Google Scholar 

  21. Buvat J., Lemaire A., Buvat-Herbaut M., Fourlinne J.C, Racadot A., Fossat P. Hyperprolactinemia and sexual function in men. Horm. Res. 22: 196, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Nielsen J., Wohlert M. Sex chromosome abnormalities found among 34910 newborn children: results from a 13-year incidence study in Arthus, Denmark. Birth Defects 26: 209, 1990.

    PubMed  CAS  Google Scholar 

  23. Magrini G., Ebiner J.R., Burckhardt P., Felber J.P. Study on the relationship between plasma prolactin levels and androgen metabolism in man. J. Clin. Endocrinol. Metab. 43: 944, 1976.

    Article  PubMed  CAS  Google Scholar 

  24. Rittmaster R.S. Finasteride. N. Engl. J. Med. 330: 120, 1994.

    Article  PubMed  CAS  Google Scholar 

  25. Sharpe R.M., Mc Neilly A.S. The effect of induced hyperprolactinaemia on leydig cell function and LH-induced loss of LH-receptor in the rat testis. Mol. Cell. Endocrinol. 16: 19, 1979.

    Article  PubMed  CAS  Google Scholar 

  26. Burrow G.N., Wortzman G., Rewcastle N.B., Holgate R., Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N. Engl. J. Med. 15: 156, 1981.

    Article  Google Scholar 

  27. Prior J.C., Cox T.A., Fairholm D., Kostashuk E., Nugent R. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J. Clin. Endocrinol. Metab. 64: 391, 1987.

    Article  PubMed  CAS  Google Scholar 

  28. Franks S. Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin. Sci. 65: 457, 1983.

    PubMed  CAS  Google Scholar 

  29. Gooren L.J.C., Assies J., Asscheman H., de Siegte R., van Kessel H. Estrogen-induced prolactinoma in a man. J. Clin. Endocrinol. Metab. 66: 444, 1988.

    Article  PubMed  CAS  Google Scholar 

  30. Wiklund J.A., Gorski J. Genetic differences in estrogen-induced deoxyribonucleic acid synthesis in the rat pituitary: correlations with pituitary tumor susceptibility. Endocrinology 111: 1140, 1982.

    Article  PubMed  CAS  Google Scholar 

  31. Bevan J.S., Sussman J., Roberts A. Hourihan M., Peters J.R. Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case Report. Br. J. Obstet. Gynecol. 96: 1440, 1989.

    Article  CAS  Google Scholar 

  32. Garcia M.M., Kapcala L.P. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy. J. Endocrinol. Invest. 18: 450, 1995.

    Article  PubMed  CAS  Google Scholar 

  33. Stefaneau L., Kovacs K. Immunocytochemistry approach to demonstrate the estrogen receptor in human adenohypophyses and pituitary adenomas with monoclonal antibody. Med. Sci. Res. 16: 449, 1988.

    Google Scholar 

  34. Stefaneanu L., Kovacs K., Horvath E., Lloyd V., Buchfelder M., Fahlbusch R., Smyth H. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J. Clin. Endocrinol. Metab. 78: 83, 1994.

    PubMed  CAS  Google Scholar 

  35. Thapar K., Kovacs K., Laws E.R., Muller P.J. Pituitary adenomas: current concepts in classification, histopathology, and molecular biology. The Endocrinologist 3: 39, 1993.

    Article  Google Scholar 

  36. Borgundvaag B., Kudlow J.E., Mueller S.C., George S.R. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-α gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 130: 3453, 1992.

    PubMed  CAS  Google Scholar 

  37. Sirbasku D.A. Estrogen induction of growth factors specific for hormone responsive mammary, pituitary and kidney tumor cells. Proc. Natl. Acad. Sci USA. 75: 3786, 1978.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  38. Mc Andrew J., Paterson A.J., Asa S., Kudlow E. Transforming growth factor-α overexpression in the pituitary of transgenic mice. 76th Annual Meeting of Endocrine Society, Anaheim 1994, abstract 25, p. 207 (Abstract).

  39. Ramsdell J.S. Transforming growth factor α and ß are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endocrinology 128: 1981, 1991.

    Article  PubMed  CAS  Google Scholar 

  40. Burns G., Sarkar D.K. Transforming growth factor-β1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133: 1444, 1993.

    PubMed  CAS  Google Scholar 

  41. Salbenblatt J.A., Bender B.G., Puck M.H., Robinson A., Faiman C., Winter J.S.D. Pituitary-gonadal function in Klinefelter’s syndrome before and during puberty. Pediatr. Res. 19: 82, 1985.

    Article  PubMed  CAS  Google Scholar 

  42. Sharma M.K.G., Balasinor N.L., Juneja H.S. Modulation of pituitary gonadotropins and prolactin secretion by testosterone in vitro. J. Endocrinol. Invest. 75: 549, 1992.

    Article  Google Scholar 

  43. Cheikh I.E., Hamilton B.P.M., Hsu T.H., Wiswell J.G. Studies using releasing factors in Klinefelter’s syndrome: The responses of LH and FSH to luteinizing hormone-releasing hormone and prolactin and TSH to thyrotropin-releasing hormone before and after testosterone. Psychoneuroendocrinology 6: 37, 1981.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil

    Ana Claudia de A. R. Pinto M.D., W. Mussio & A. M. J. Lengyel

  2. Department of Medicine, Universidade Federal do Rio Grande do Sul, Brazil

    M. A. Czepielewski & J. L. Gross

Authors
  1. Ana Claudia de A. R. Pinto M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Czepielewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. L. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Mussio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. M. J. Lengyel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinto, A.C.A.R., Czepielewski, M.A., Gross, J.L. et al. A prolactin-secreting tumor in a patient with Klinefelter’s syndrome: A case report. J Endocrinol Invest 19, 248–252 (1996). https://doi.org/10.1007/BF03349876

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349876

Key-words

Search

Navigation